文献速递肾小球疾病肾移植

IgM型单克隆免疫球蛋白沉积的增生性肾小球肾炎病例系列

IgM Variant of Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits: A Case Series.
PubMed 文献 · Am J Kidney Dis · 2025-03-25

该病例系列描述了23例IgM变异型PGNMID(PGNMID-IgM)的临床病理特征与结局。患者多为老年男性,均伴肾脏意义单克隆丙种球蛋白病(MGRS),血清免疫固定电泳检出率低,MALDI-TOF可提高检出。肾脏生存中位44个月,移植后复发率高,但患者总体生存较好。

要点

  • PGNMID-IgM罕见,多见于老年男性,均与MGRS相关。
  • SPEP/SIF对致病性单克隆IgM检出率低,MALDI-TOF或可提高检出。
  • 肾脏生存中位44个月,移植后早期复发率高。

核心结论

  • PGNMID-IgM主要累及老年男性,与MGRS相关,肾脏生存有限,移植后早期复发率高,但患者总体生存良好。

研究设计与样本

  • 病例系列研究,从肾脏病理档案中识别23例PGNMID-IgM病例。
  • PGNMID-IgM定义为肾小球颗粒状单型IgM沉积的肾小球肾炎,并排除冷球蛋白性肾小球肾炎和毛细血管内单克隆沉积病。

主要发现

  • 31%病例存在低补体血症,所有病例的基础血液学疾病均为MGRS。
  • SPEP/SIF检出致病性单克隆免疫球蛋白者占27%,MALDI-TOF在7例受检者中检出4例。
  • 肾活检显示膜增生性肾小球肾炎占83%,非组织性肾小球单型IgM沉积占100%,C3沉积占96%,C1q沉积罕见。
  • 中位随访40个月,肾脏和患者生存中位分别为44个月和158个月;3例接受肾移植,均复发,其中2例在1个月内复发。

临床怎么用

  • 对疑诊PGNMID-IgM者应行肾活检及免疫病理检查,并筛查MGRS。
  • SPEP/SIF阴性时,可考虑MALDI-TOF检测致病性单克隆IgM。
  • 肾移植前应评估复发风险,移植后需密切监测早期复发。

局限性

  • 样本量小,为回顾性设计,临床管理未标准化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Most deposits in proliferative glomerulonephritis with monoclonal immunoglobulin deposits (PGNMID) are of the IgG class. The IgM variant (PGNMID-IgM) is very rare, and data are mostly derived from single case reports or cases associated with B-cell lymphoproliferative disorders. We describe the clinicopathologic characteristics and outcomes among cases of PGNMID-IgM. STUDY DESIGN: Case series. SETTING & PARTICIPANTS: 23 PGNMID-IgM cases identified from kidney pathology archives. PGNMID-IgM was defined by glomerulonephritis with glomerular granular monotypic IgM deposits after excluding cryoglobulinemic glomerulonephritis and intracapillary monoclonal deposits disease. FINDINGS: Seventy-eight percent of the cases were male, they had a median age of 72 years, and they had presented with proteinuria (median, 3.1g/day), hematuria (91%), and reduced estimated glomerular filtration rate (median serum creatinine, 1.9mg/dL). Hypocomplementemia was present in 31% of cases. The underlying hematologic condition for all cases was monoclonal gammopathy of renal significance (MGRS). Serum protein electrophoresis/serum immunofixation (SPEP/SIF) detected the nephropathic monoclonal immunoglobulin (MIg) in 27% of cases whereas matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF) detected the nephropathic IgM in 4 of 7 tested patients. Kidney biopsy revealed membranoproliferative glomerulonephritis (83%) with nonorganized glomerular monotypic IgM (100%) and C3 deposition (96%), but C1q deposition was rare. Seventeen percent received symptomatic treatment alone, 17% received steroids alone, and 65% received other immunosuppressive therapy (mostly rituximab-based therapy). Follow-up (median, 40 months) was available for all patients. The median kidney and patient survivals were 44 and 158 months, respectively. Three patients underwent kidney transplantation, and all had recurrence, in 2 cases within a month. LIMITATIONS: Small sample size, retrospective design, nonstandardized clinical management. CONCLUSIONS: PGNMID-IgM mostly affects elderly men and is associated with MGRS with a low detection rate of the circulating nephropathic MIg on SPEP/SIF, which may be improved by MALDI-TOF. Kidney survival is guarded, with a high rate of early recurrence after transplant although overall survival is favorable. The pathogenesis remains unknown, but it likely involves local activation of alternative or lectin pathways of complement system by the monotypic IgM. PLAIN-LANGUAGE SUMMARY: The IgM variant of proliferative glomerulonephritis with monoclonal immunoglobulin deposits (PGNMID-IgM) is very rare, and data on its clinicopathologic and outcome characteristics are scanty. This study of 23 patients with PGNMID-IgM identified in the Mayo Clinic pathology archives revealed that most patients were elderly White males who presented with proteinuria, hematuria, and reduced kidney function. The underlying hematologic condition was monoclonal gammopathy of renal significance in all cases, and the detection rate of the circulating nephropathic monoclonal immunoglobulin with serum protein electrophoresis/serum immunofixation was low but was increased using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Pathologically, all cases exhibited nonorganized glomerular monotypic IgM, most with a membranoproliferative glomerulonephritis pattern. Outcome analysis revealed a guarded kidney survival (median, 44 months), a high rate of early recurrence after transplant, and favorable patient survival (158 months).

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Bu L, Valeri AM, Said SM, et al. IgM Variant of Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits: A Case Series. Am J Kidney Dis. 2025. PMID: 40147751. doi:10.1053/j.ajkd.2025.01.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。